Developer docs
API playgroundTry for free, no card

Search company profiles

ZOLL Medical Corporation

Full company profile

uuid0004k37

Namestring
ZOLL Medical Corporation
Legal namestring
ZOLL Medical Corporation
Websiteurl
zoll.com
Company typeenum
Private
Founded yearint
1980
Descriptiontext

ZOLL Medical Corporation, founded in 1980 and headquartered in Chelmsford, Massachusetts, is a wholly-owned subsidiary of the Japanese diversified conglomerate Asahi Kasei (TYO: 3407). The company designs, manufactures, and sells medical devices and software for cardiopulmonary resuscitation, cardiac monitoring, temperature management, and sleep apnea diagnosis and treatment. Its product portfolio spans public-access automated external defibrillators (AED 3, AED Plus, AED Pro), professional monitor/defibrillators (X Series, X Series Advanced, R Series, Propaq MD/M), the AutoPulse NXT automated CPR system, the LifeVest wearable cardioverter-defibrillator, the TherOx SuperSaturated Oxygen Therapy catheter system, the Thermogard intravascular temperature management platform, the WatchPAT home sleep apnea test, the remedē implantable system for central sleep apnea, and an extensive software ecosystem (RescueNet CaseReview/CodeWriter/CodeNet/Live/12-Lead/EventSummary, DeviceDashboard, PlusTrac, emsCharts, Dispatch, Billing, AR Boost, Care Exchange). Underlying technologies include proprietary Real CPR Help accelerometer-based feedback (standard since 2002), Rectilinear Biphasic defibrillation waveform, See-Thru CPR artifact filtering, and TRENDS remote patient monitoring analytics.

The business operates across seven primary customer segments — EMS and fire services, hospitals, public access/community, government and military, cardiac patient management, sleep apnea, and non-acute care — and distributes through a global enterprise field sales force, e-commerce (zollwebstore.com), exclusive distribution partnerships (e.g., BrainCool), and co-marketing relationships (Boston Red Sox/Fenway Park, RCX Sports Foundation, PulsePoint Foundation). Revenue is generated through capital hardware sales (defibrillators, monitors, ventilators, AEDs, temperature management systems, LifeVest, remedē, TherOx), recurring accessories and consumables (electrodes, batteries, cables), software subscriptions (RescueNet, DeviceDashboard, PlusTrac, emsCharts, Billing), and ExpertCare service plans. The company reported $2.4 billion in revenue for 2024, having grown nearly fivefold since 2010, and employs between 1,001 and 5,000 people across operations in the United States, Israel, Japan, and 13 additional countries.

Strategic growth has been driven by serial acquisitions — Itamar Medical in December 2021 (sleep apnea), TherOx in 2019 (SSO2 therapy), Cardiac Science in 2019 (AEDs), Respicardia in 2021 (remedē), and the Vyaire Medical ventilator business in 2024 — combined with organic product launches such as the Zenix Monitor/Defibrillator in 2025. Effective April 1, 2026, Eric Knudsen succeeded Jon Rennert as CEO; Knudsen brings a Corporate Development background and led the ZOLL Itamar division through its post-acquisition expansion. The company faces material regulatory headwinds from an FDA Warning Letter issued April 30, 2026, citing Quality System Regulation violations and medical device reporting failures across X Series AEDs, MRI-compatible ventilators, and electrodes at its Chelmsford facility.

Short descriptiontext

ZOLL Medical Corporation, an Asahi Kasei subsidiary founded in 1980, develops and markets medical devices and software for cardiopulmonary resuscitation, cardiac monitoring, temperature management, and sleep apnea diagnosis and treatment. It serves EMS, hospitals, government/military, and public access markets globally, generating $2.4 billion in 2024 revenue.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersChelmsford, United States
HQ citystring
Chelmsford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device manufacturing, defibrillator and AED sales, cardiac resuscitation technology, EMS and hospital software, sleep apnea diagnostics
Industry5 codes
1Cardiac Rhythm Management (Pacemakers, ICDs, CRT)
CodeHLAHAFACPrimaryYes
2Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)
CodeHLAHAFALPrimaryNo
3Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)
CodeHSABAKADPrimaryNo
4Medical-Grade Device Connectivity & Device Management (MDM)
CodeHLACAFAGPrimaryNo
5Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
CodeHLALAFAAPrimaryNo
NAICS code1 code
  • Health Care and Social Assistance62
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
  • Hospital & Medical Service Plans6324
Product category
Medical Devices and Software for Cardiopulmonary Resuscitation
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

ZOLL generates revenue primarily through the sale of professional medical devices including defibrillators, AEDs, ventilators, monitors, automated CPR devices, and temperature management systems. These are typically one-time capital equipment purchases with varying price points based on device complexity.

zoll.com
2Software Subscriptions and Licensing
TypeSubscription Recurring
Description

Revenue from software solutions including RescueNet suite (CaseReview, CodeWriter, CodeNet, Live, 12-Lead), DeviceDashboard, PlusTrac AED management, EMS Billing, Dispatch, and emsCharts. Cloud-based solutions likely follow subscription or license models.

zoll.com
3Accessories and Consumables
TypeHardware Sales
Description

Ongoing revenue from electrodes, batteries, cables, circuits, and other accessories required for device operation. Recurring revenue stream from consumables used with installed device base.

zoll.com
4Therapy Devices
TypeHardware Sales
Description

Sale of therapeutic devices including LifeVest wearable defibrillator, remedē System implantable sleep apnea device, and TherOx SSO2 Therapy system.

zoll.com
5Service and Support
TypeProfessional Services
Description

Revenue from ExpertCare service plans, technical training, and support services for installed customer base.

bostonglobe.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Professional medical devices (defibrillators, monitors, ventilators) - pricing based on device type and configuration
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available. Professional medical devices require consultation with sales team for configuration and quote.

zoll.com
2Software solutions - cloud-based subscriptions
ModelSubscriptionBilling cadenceAnnual
Notes

ZOLL offers cloud-based software solutions including DeviceDashboard, RescueNet suite, and billing software. Specific pricing not publicly disclosed.

zoll.com
3Accessories and electrodes - unit pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Electrodes, batteries, cables, and other accessories available through ZOLL Webstore. Pricing not publicly listed on website.

zoll.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1ZOLL Itamar
Description

Sleep apnea diagnosis and management solutions including WatchPAT home sleep apnea test

zoll.com
+10 more records
Core offering1 text field

ZOLL Medical Corporation develops, manufactures, and markets professional medical devices and software for cardiopulmonary resuscitation, cardiac monitoring and defibrillation, temperature management, automated CPR, sleep apnea diagnosis and treatment, and EMS/hospital data management. Its portfolio spans automated external defibrillators (AEDs), professional monitor/defibrillators, the LifeVest wearable cardioverter-defibrillator, WatchPAT home sleep apnea tests, the remedē System implantable central sleep apnea device, TherOx SuperSaturated Oxygen Therapy, Thermogard temperature management systems, the AutoPulse automated CPR platform, and the RescueNet software suite (CaseReview, CodeWriter, CodeNet, Live, 12-Lead, EventSummary, DeviceDashboard, PlusTrac, emsCharts, Dispatch, Billing, AR Boost, Care Exchange). Customers include EMS agencies, hospitals, government/military buyers, public access venues, and cardiac patients across more than 30 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 23.4+ hour/day median patient compliance rate with LifeVest wearable defibrillator
+5 more records
Product overview1 text field

ZOLL Medical Corporation, an Asahi Kasei company, offers a comprehensive portfolio of medical devices and software solutions for cardiopulmonary and respiratory care across the continuum of care. The product portfolio includes: AEDs (ZOLL AED 3, AED Plus, AED Pro) for public access and professional use with Real CPR Help technology; professional monitor/defibrillators (X Series, X Series Advanced, R Series, Propaq MD/M) for EMS, hospital, and military settings; automated CPR systems (AutoPulse NXT); LifeVest wearable cardioverter defibrillator for sudden cardiac death protection; sleep apnea solutions (WatchPAT home sleep apnea test and remedē System for central sleep apnea); TherOx SuperSaturated Oxygen Therapy for STEMI treatment; temperature management systems (Thermogard XP/HQ); and an extensive software ecosystem (RescueNet Suite including CaseReview, CodeWriter, CodeNet, Live, 12-Lead, EventSummary; DeviceDashboard; PlusTrac; emsCharts; Dispatch; Billing; AR Boost; Care Exchange) for data management, quality improvement, billing optimization, and interoperability. ZOLL operates across public safety, EMS, fire, hospital, non-acute care, government/military, and cardiac patient management market segments.

Product and service32 records
1ZOLL AED 3
CategoryAutomated External Defibrillator (AED)
Description

Automated external defibrillator with Real CPR Help technology providing audio and visual feedback to guide rescuers in delivering high-quality CPR. For public access and lay rescuers.

2ZOLL AED Plus
CategoryAutomated External Defibrillator (AED)
Description

Automated external defibrillator featuring Real CPR Help with one-piece CPR-D-Padz and voice and text prompts including 'Push Harder' and 'Good Compressions' feedback. For public access and lay rescuers.

3AED Pro
CategoryAutomated External Defibrillator (AED)
Description

Professional-grade automated external defibrillator with manual override capability and Real CPR Help feedback for advanced rescuers.

4X Series Monitor/Defibrillator
CategoryProfessional Monitor/Defibrillator
Description

Lightweight (under 12 pounds), full-featured monitor/defibrillator for patients of all ages from neonates to adults, featuring Real CPR Help and 10 physiologic parameters including NIBP, EtCO2, SpO2, and invasive blood pressures. For EMS and hospital use.

5X Series Advanced Monitor/Defibrillator
CategoryProfessional Monitor/Defibrillator
Description

Advanced monitor/defibrillator featuring Real BVM Help for ventilation feedback, TBI Dashboard for traumatic brain injury patient management, and RescueNet CaseReview integration for post-case performance data review. For EMS and hospital advanced life support.

6R Series Defibrillator/Monitor
CategoryProfessional Monitor/Defibrillator
Description

Professional defibrillator/monitor for advanced life support featuring Real CPR Help, CPR Dashboard, and CodeNet compatibility for hospital resuscitation teams.

7Propaq MD Transport Monitor/Defibrillator
CategoryProfessional Monitor/Defibrillator
Description

Transport monitor/defibrillator for EMS and hospital transport with advanced monitoring capabilities.

8Propaq M Military Monitor/Defibrillator
CategoryProfessional Monitor/Defibrillator
Description

Military-grade trusted and proven monitor/defibrillator designed for military and tactical EMS operations.

9Zenix Monitor/Defibrillator
CategoryProfessional Monitor/Defibrillator
Description

ZOLL's most clinically advanced and easy-to-use professional monitor/defibrillator, featuring innovative, intuitive interface with brilliant visual display.

10AutoPulse NXT Resuscitation System
CategoryAutomated CPR System
Description

Automated CPR device providing consistent, high-quality chest compressions during cardiac arrest, featuring patient-customized compression delivery for field and transport use.

11LifeVest Wearable Cardioverter Defibrillator (WCD)
CategoryWearable Cardiac Therapy
Description

Proven sudden cardiac death protection device providing actionable insights into cardiac recovery with automatic detection and treatment of life-threatening arrhythmias.

12TherOx SuperSaturated Oxygen (SSO2) Therapy
CategoryCardiovascular Therapy
Description

First FDA-approved catheter-based therapy to reduce infarct size by delivering high levels of dissolved oxygen to the heart immediately following PCI in STEMI patients, demonstrating 26% relative median size reduction.

13WatchPAT Home Sleep Apnea Test
CategorySleep Apnea Diagnostics
Description

FDA-cleared innovative home sleep apnea test utilizing peripheral arterial tonometry signal for simple, accurate, and reliable sleep apnea diagnosis. Also FDA-cleared to identify AFib events and premature beats.

14remedē System
CategorySleep Apnea Therapy
Description

First FDA-approved non-mask therapy for moderate to severe central sleep apnea, featuring an implantable device that automatically activates to restore normal breathing patterns during sleep.

15Thermogard XP Temperature Management System
CategoryTemperature Management
Description

Intravascular temperature management system for precise patient temperature control in critical care settings.

16Thermogard HQ Temperature Management System
CategoryTemperature Management
Description

Advanced temperature management system for therapeutic hypothermia and normothermia maintenance in hospital settings.

17RescueNet CaseReview
CategoryHospital Software
Description

Data management software providing snapshot of all data points collected during a code for immediate debriefing and aggregate data for quality improvement initiatives.

18RescueNet CodeWriter
CategoryHospital Software
Description

Handheld tablet application allowing scribes to take sophisticated notes during a code with real-time guidance and organization.

19RescueNet CodeNet
CategoryHospital Software
Description

Integrated software combining CodeWriter notes directly into CaseReview data management for seamless post-event analysis and quality improvement.

20RescueNet Live
CategoryHospital Software
Description

Telehealth solution enabling clinicians to view real-time data from ZOLL X Series Advanced devices used by EMS teams during patient transport.

21RescueNet 12-Lead
CategoryHospital Software
Description

Complete STEMI management platform facilitating efficient data sharing of 12-lead ECG from EMS to hospital to expedite patient care.

22RescueNet EventSummary
CategoryPublic Access Software
Description

Software capturing all clinical data from ZOLL AEDs for quality review, analysis, and post-event debriefing.

23DeviceDashboard
CategoryHospital Software
Description

Cloud-based remote monitoring platform allowing wireless viewing of all connected defibrillators, health assessment, and troubleshooting from a centralized dashboard.

24PlusTrac AED Program Management
CategoryPublic Access Software
Description

Interactive web-based solution for AED program administration, compliance tracking, and device health monitoring.

25ZOLL emsCharts
CategoryEMS Software
Description

Cloud-based patient care report documentation system designed for modern EMS workflows with anytime/anywhere access via computers, tablets, and mobile devices.

26ZOLL Dispatch
CategoryEMS Software
Description

Computer-aided dispatch and call-taking solution enabling quick response, effective communication, and quality outcomes with robust monitoring and QA functionality.

27ZOLL Billing
CategoryEMS Software
Description

Cloud-based EMS billing software automating workflows, eliminating billing errors, and ensuring compliance with current codes and fee schedules.

28ZOLL AR Boost
CategoryEMS Software
Description

Automated accounts receivable optimization solution automatically finding, correcting, and verifying patient and payer information to capture more revenue.

29ZOLL Care Exchange
CategoryEMS Software
Description

Interoperability platform facilitating bi-directional data flow between EMS, hospitals, and vendors in near real-time.

30Mobilize Rescue App
CategoryPublic Access Software
Description

Just-in-time instructional app providing step-by-step directions, interactive prompts, written instructions, and visual cues for using medical supplies in Mobilize trauma kits during emergencies.

31ZOLL Webstore (Accessories and Consumables)
CategoryAccessories and Consumables
Description

Direct e-commerce storefront (zollwebstore.com) for accessories including electrodes, batteries, cables, and circuits required for ZOLL device operation.

32ExpertCare Service Plans
CategoryService and Support
Description

Service and support plans providing technical training and support services for the installed ZOLL device base.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

PulsePoint Foundation and ZOLL announced the Anyone Can Register initiative to expand the National Emergency AED Registry (NEAR) by mobilizing volunteers and AED manufacturers to add devices in their communities. Program launching February 2026 aims to make AED locations more accessible and improve cardiac arrest response.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-07-01
Description

ZOLL Medical Corporation received exclusive distribution rights for BrainCool's temperature management products across the United States and major European markets in July 2023. This partnership expands ZOLL's temperature management portfolio for critical care applications.

Strategic tierCoreTypeGTM or Marketing Partner
Description

ZOLL partners with RCX Sports Foundation to provide AEDs through grant programs as part of the 'Anything Can Happen. Anyone Can Help.' campaign to strengthen cardiac emergency readiness in youth sports across the United States.

Strategic tierFlagshipTypeGTM or Marketing Partner
Description

ZOLL is the Official AED provider for Fenway Park and the Boston Red Sox, establishing the venue as a model for cardiac preparedness. This partnership positions ZOLL as the trusted AED brand in high-profile sports settings.

5National Emergency AED Registry
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ZOLL participates in the National Emergency AED Registry (NEAR) managed by PulsePoint Foundation, with approximately 212,000 of estimated 1.1 million AEDs deployed nationwide currently registered in the system.

businesswire.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Owns Physio-Control/LifePak and HeartSine — the most direct global competitor to ZOLL's monitor/defibrillators and AED lines. Competes head-to-head in EMS, hospital, and public-access defibrillation.

TypeBroad incumbent
Description

Historically competed with HeartStart AEDs and has overlapping patient-monitoring/hospital informatics offerings. Broader portfolio but meaningful overlap in hospital resuscitation and connected care.

TypeDirect peer
Description

Major cardiac rhythm management incumbent (ICDs, CRT, ablation) and one of the three majority-share holders in sleep apnea implants alongside ZOLL. Direct competitor across implantable and adjacent cardiac device categories.

TypeDirect peer
Description

Cardiac rhythm management and electrophysiology competitor. Competes in hospital cardiology where ZOLL's LifeVest, X Series, and RescueNet are deployed, and has growing sleep apnea/surgical franchises.

TypeDirect peer
Description

Direct competitor in the implantable sleep apnea market — Inspire's hypoglossal nerve stimulation competes head-to-head with ZOLL's remedē System for central sleep apnea treatment.

TypeDirect peer
Description

Cardiovascular and cardiac rhythm management (ICDs, CRT-D) competitor; also competes in hospital diagnostics and remote monitoring relevant to ZOLL's TRENDS and RescueNet ecosystem.

TypeDirect peer
Description

Global leader in sleep apnea (PAP therapy, masks, diagnostics). Competes with ZOLL Itamar (WatchPAT, remedē) in the sleep apnea diagnosis and treatment continuum.

TypeDirect peer
Description

Japanese patient monitoring and defibrillator manufacturer with overlapping product categories — particularly relevant as a regional competitor in APAC and EMS/hospital monitoring.

TypeEmerging player
Description

Chinese medical device maker with growing global share in patient monitoring, AEDs, and defibrillators. Increasingly competitive on price-performance in EMS and emerging markets.

TypeBroad incumbent
Description

Hospital-wide patient monitoring and anesthesia/critical care portfolio overlaps ZOLL's hospital, critical care, and connected-care offerings; broad incumbent rather than cardiac specialist.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A15 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ZOLL Medical Corporation

Medical Devices and Software for Cardiopulmonary Resuscitationzoll.com

ZOLL Medical Corporation, an Asahi Kasei subsidiary founded in 1980, develops and markets medical devices and software for cardiopulmonary resuscitation, cardiac monitoring, temperature management, and sleep apnea diagnosis and treatment. It serves EMS, hospitals, government/military, and public access markets globally, generating $2.4 billion in 2024 revenue.

What ZOLL Medical Corporation does

ZOLL Medical Corporation, founded in 1980 and headquartered in Chelmsford, Massachusetts, is a wholly-owned subsidiary of the Japanese diversified conglomerate Asahi Kasei (TYO: 3407). The company designs, manufactures, and sells medical devices and software for cardiopulmonary resuscitation, cardiac monitoring, temperature management, and sleep apnea diagnosis and treatment. Its product portfolio spans public-access automated external defibrillators (AED 3, AED Plus, AED Pro), professional monitor/defibrillators (X Series, X Series Advanced, R Series, Propaq MD/M), the AutoPulse NXT automated CPR system, the LifeVest wearable cardioverter-defibrillator, the TherOx SuperSaturated Oxygen Therapy catheter system, the Thermogard intravascular temperature management platform, the WatchPAT home sleep apnea test, the remedē implantable system for central sleep apnea, and an extensive software ecosystem (RescueNet CaseReview/CodeWriter/CodeNet/Live/12-Lead/EventSummary, DeviceDashboard, PlusTrac, emsCharts, Dispatch, Billing, AR Boost, Care Exchange). Underlying technologies include proprietary Real CPR Help accelerometer-based feedback (standard since 2002), Rectilinear Biphasic defibrillation waveform, See-Thru CPR artifact filtering, and TRENDS remote patient monitoring analytics.

The business operates across seven primary customer segments — EMS and fire services, hospitals, public access/community, government and military, cardiac patient management, sleep apnea, and non-acute care — and distributes through a global enterprise field sales force, e-commerce (zollwebstore.com), exclusive distribution partnerships (e.g., BrainCool), and co-marketing relationships (Boston Red Sox/Fenway Park, RCX Sports Foundation, PulsePoint Foundation). Revenue is generated through capital hardware sales (defibrillators, monitors, ventilators, AEDs, temperature management systems, LifeVest, remedē, TherOx), recurring accessories and consumables (electrodes, batteries, cables), software subscriptions (RescueNet, DeviceDashboard, PlusTrac, emsCharts, Billing), and ExpertCare service plans. The company reported $2.4 billion in revenue for 2024, having grown nearly fivefold since 2010, and employs between 1,001 and 5,000 people across operations in the United States, Israel, Japan, and 13 additional countries.

Strategic growth has been driven by serial acquisitions — Itamar Medical in December 2021 (sleep apnea), TherOx in 2019 (SSO2 therapy), Cardiac Science in 2019 (AEDs), Respicardia in 2021 (remedē), and the Vyaire Medical ventilator business in 2024 — combined with organic product launches such as the Zenix Monitor/Defibrillator in 2025. Effective April 1, 2026, Eric Knudsen succeeded Jon Rennert as CEO; Knudsen brings a Corporate Development background and led the ZOLL Itamar division through its post-acquisition expansion. The company faces material regulatory headwinds from an FDA Warning Letter issued April 30, 2026, citing Quality System Regulation violations and medical device reporting failures across X Series AEDs, MRI-compatible ventilators, and electrodes at its Chelmsford facility.

ZOLL Medical Corporation firmographics

Firmographics
Name
ZOLL Medical Corporation
Legal name
ZOLL Medical Corporation
Website
https://zoll.com
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
ZOLL Medical Corporation, an Asahi Kasei subsidiary founded in 1980, develops and markets medical devices and software for cardiopulmonary resuscitation, cardiac monitoring, temperature management, and sleep apnea diagnosis and treatment. It serves EMS, hospitals, government/military, and public access markets globally, generating $2.4 billion in 2024 revenue.
Ownership category
akta.pro rank

ZOLL Medical Corporation industry classification

Industry
Product category
Medical Devices and Software for Cardiopulmonary Resuscitation
NAICS
Health Care and Social Assistance (62)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Hospital & Medical Service Plans (6324)
akta.pro primary industry
Cardiac Rhythm Management (Pacemakers, ICDs, CRT) (HLAHAFAC)
akta.pro secondary industries
Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

  • Medical device manufacturing
  • Defibrillator and AED sales
  • Cardiac resuscitation technology
  • EMS and hospital software
  • Sleep apnea diagnostics

Where ZOLL Medical Corporation is headquartered

Location

Headquarters

HQ city
Chelmsford
HQ country
United States
HQ region
North America

Offices4 records

Markets served

ZOLL Medical Corporation business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Device Hardware Sales: ZOLL generates revenue primarily through the sale of professional medical devices including defibrillators, AEDs, ventilators, monitors, automated CPR devices, and temperature management systems. These are typically one-time capital equipment purchases with varying price points based on device complexity.
  2. Software Subscriptions and Licensing: Revenue from software solutions including RescueNet suite (CaseReview, CodeWriter, CodeNet, Live, 12-Lead), DeviceDashboard, PlusTrac AED management, EMS Billing, Dispatch, and emsCharts. Cloud-based solutions likely follow subscription or license models.
  3. Accessories and Consumables: Ongoing revenue from electrodes, batteries, cables, circuits, and other accessories required for device operation. Recurring revenue stream from consumables used with installed device base.
  4. Therapy Devices: Sale of therapeutic devices including LifeVest wearable defibrillator, remedē System implantable sleep apnea device, and TherOx SSO2 Therapy system.
  5. Service and Support: Revenue from ExpertCare service plans, technical training, and support services for installed customer base.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProfessional medical devices (defibrillators, monitors, ventilators) - pricing based on device type and configuration
SubscriptionAnnualSoftware solutions - cloud-based subscriptions
Unit PricingPay-as-you-goAccessories and electrodes - unit pricing

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

ZOLL Medical Corporation product offering

Product offering

Core offering

ZOLL Medical Corporation develops, manufactures, and markets professional medical devices and software for cardiopulmonary resuscitation, cardiac monitoring and defibrillation, temperature management, automated CPR, sleep apnea diagnosis and treatment, and EMS/hospital data management. Its portfolio spans automated external defibrillators (AEDs), professional monitor/defibrillators, the LifeVest wearable cardioverter-defibrillator, WatchPAT home sleep apnea tests, the remedē System implantable central sleep apnea device, TherOx SuperSaturated Oxygen Therapy, Thermogard temperature management systems, the AutoPulse automated CPR platform, and the RescueNet software suite (CaseReview, CodeWriter, CodeNet, Live, 12-Lead, EventSummary, DeviceDashboard, PlusTrac, emsCharts, Dispatch, Billing, AR Boost, Care Exchange). Customers include EMS agencies, hospitals, government/military buyers, public access venues, and cardiac patients across more than 30 countries.

Product overview

ZOLL Medical Corporation, an Asahi Kasei company, offers a comprehensive portfolio of medical devices and software solutions for cardiopulmonary and respiratory care across the continuum of care. The product portfolio includes: AEDs (ZOLL AED 3, AED Plus, AED Pro) for public access and professional use with Real CPR Help technology; professional monitor/defibrillators (X Series, X Series Advanced, R Series, Propaq MD/M) for EMS, hospital, and military settings; automated CPR systems (AutoPulse NXT); LifeVest wearable cardioverter defibrillator for sudden cardiac death protection; sleep apnea solutions (WatchPAT home sleep apnea test and remedē System for central sleep apnea); TherOx SuperSaturated Oxygen Therapy for STEMI treatment; temperature management systems (Thermogard XP/HQ); and an extensive software ecosystem (RescueNet Suite including CaseReview, CodeWriter, CodeNet, Live, 12-Lead, EventSummary; DeviceDashboard; PlusTrac; emsCharts; Dispatch; Billing; AR Boost; Care Exchange) for data management, quality improvement, billing optimization, and interoperability. ZOLL operates across public safety, EMS, fire, hospital, non-acute care, government/military, and cardiac patient management market segments.

Differentiator

Problem solved

Functional benefit

Brands

  • ZOLL Itamar: Sleep apnea diagnosis and management solutions including WatchPAT home sleep apnea test
  • LifeVest
  • remede System
  • RescueNet
  • Real CPR Help
  • Thermogard
  • AutoPulse
  • TherOx
  • X Series
  • R Series
  • ZOLL AED

Products and services

  • ZOLL AED 3 Automated external defibrillator with Real CPR Help technology providing audio and visual feedback to guide rescuers in delivering high-quality CPR. For public access and lay rescuers.
  • ZOLL AED Plus Automated external defibrillator featuring Real CPR Help with one-piece CPR-D-Padz and voice and text prompts including 'Push Harder' and 'Good Compressions' feedback. For public access and lay rescuers.
  • AED Pro Professional-grade automated external defibrillator with manual override capability and Real CPR Help feedback for advanced rescuers.
  • X Series Monitor/Defibrillator Lightweight (under 12 pounds), full-featured monitor/defibrillator for patients of all ages from neonates to adults, featuring Real CPR Help and 10 physiologic parameters including NIBP, EtCO2, SpO2, and invasive blood pressures. For EMS and hospital use.
  • X Series Advanced Monitor/Defibrillator Advanced monitor/defibrillator featuring Real BVM Help for ventilation feedback, TBI Dashboard for traumatic brain injury patient management, and RescueNet CaseReview integration for post-case performance data review. For EMS and hospital advanced life support.
  • R Series Defibrillator/Monitor Professional defibrillator/monitor for advanced life support featuring Real CPR Help, CPR Dashboard, and CodeNet compatibility for hospital resuscitation teams.
  • Propaq MD Transport Monitor/Defibrillator Transport monitor/defibrillator for EMS and hospital transport with advanced monitoring capabilities.
  • Propaq M Military Monitor/Defibrillator Military-grade trusted and proven monitor/defibrillator designed for military and tactical EMS operations.
  • Zenix Monitor/Defibrillator ZOLL's most clinically advanced and easy-to-use professional monitor/defibrillator, featuring innovative, intuitive interface with brilliant visual display.
  • AutoPulse NXT Resuscitation System Automated CPR device providing consistent, high-quality chest compressions during cardiac arrest, featuring patient-customized compression delivery for field and transport use.
  • LifeVest Wearable Cardioverter Defibrillator (WCD) Proven sudden cardiac death protection device providing actionable insights into cardiac recovery with automatic detection and treatment of life-threatening arrhythmias.
  • TherOx SuperSaturated Oxygen (SSO2) Therapy First FDA-approved catheter-based therapy to reduce infarct size by delivering high levels of dissolved oxygen to the heart immediately following PCI in STEMI patients, demonstrating 26% relative median size reduction.
  • WatchPAT Home Sleep Apnea Test FDA-cleared innovative home sleep apnea test utilizing peripheral arterial tonometry signal for simple, accurate, and reliable sleep apnea diagnosis. Also FDA-cleared to identify AFib events and premature beats.
  • remedē System First FDA-approved non-mask therapy for moderate to severe central sleep apnea, featuring an implantable device that automatically activates to restore normal breathing patterns during sleep.
  • Thermogard XP Temperature Management System Intravascular temperature management system for precise patient temperature control in critical care settings.
  • Thermogard HQ Temperature Management System Advanced temperature management system for therapeutic hypothermia and normothermia maintenance in hospital settings.
  • RescueNet CaseReview Data management software providing snapshot of all data points collected during a code for immediate debriefing and aggregate data for quality improvement initiatives.
  • RescueNet CodeWriter Handheld tablet application allowing scribes to take sophisticated notes during a code with real-time guidance and organization.
  • RescueNet CodeNet Integrated software combining CodeWriter notes directly into CaseReview data management for seamless post-event analysis and quality improvement.
  • RescueNet Live Telehealth solution enabling clinicians to view real-time data from ZOLL X Series Advanced devices used by EMS teams during patient transport.
  • RescueNet 12-Lead Complete STEMI management platform facilitating efficient data sharing of 12-lead ECG from EMS to hospital to expedite patient care.
  • RescueNet EventSummary Software capturing all clinical data from ZOLL AEDs for quality review, analysis, and post-event debriefing.
  • DeviceDashboard Cloud-based remote monitoring platform allowing wireless viewing of all connected defibrillators, health assessment, and troubleshooting from a centralized dashboard.
  • PlusTrac AED Program Management Interactive web-based solution for AED program administration, compliance tracking, and device health monitoring.
  • ZOLL emsCharts Cloud-based patient care report documentation system designed for modern EMS workflows with anytime/anywhere access via computers, tablets, and mobile devices.
  • ZOLL Dispatch Computer-aided dispatch and call-taking solution enabling quick response, effective communication, and quality outcomes with robust monitoring and QA functionality.
  • ZOLL Billing Cloud-based EMS billing software automating workflows, eliminating billing errors, and ensuring compliance with current codes and fee schedules.
  • ZOLL AR Boost Automated accounts receivable optimization solution automatically finding, correcting, and verifying patient and payer information to capture more revenue.
  • ZOLL Care Exchange Interoperability platform facilitating bi-directional data flow between EMS, hospitals, and vendors in near real-time.
  • Mobilize Rescue App Just-in-time instructional app providing step-by-step directions, interactive prompts, written instructions, and visual cues for using medical supplies in Mobilize trauma kits during emergencies.
  • ZOLL Webstore (Accessories and Consumables) Direct e-commerce storefront (zollwebstore.com) for accessories including electrodes, batteries, cables, and circuits required for ZOLL device operation.
  • ExpertCare Service Plans Service and support plans providing technical training and support services for the installed ZOLL device base.

Quantifiable outcome

  • 23.4+ hour/day median patient compliance rate with LifeVest wearable defibrillator
  • +5 more outcomes

Companies that use ZOLL Medical Corporation

Customer profile

Named customers5 records

Segments7 records

Ideal customer profiles6 records

ZOLL Medical Corporation technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability6 records

Feature10 records

ZOLL Medical Corporation partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and flagship.

  • PulsePoint FoundationcoreStrategic or Co-development Partner · 1 February 2026PulsePoint Foundation and ZOLL announced the Anyone Can Register initiative to expand the National Emergency AED Registry (NEAR) by mobilizing volunteers and AED manufacturers to add devices in their communities. Program launching February 2026 aims to make AED locations more accessible and improve cardiac arrest response.
  • BrainCoolcoreChannel Partner/ Reseller/ Distributor · 1 July 2023ZOLL Medical Corporation received exclusive distribution rights for BrainCool's temperature management products across the United States and major European markets in July 2023. This partnership expands ZOLL's temperature management portfolio for critical care applications.
  • RCX Sports FoundationcoreGTM or Marketing PartnerZOLL partners with RCX Sports Foundation to provide AEDs through grant programs as part of the 'Anything Can Happen. Anyone Can Help.' campaign to strengthen cardiac emergency readiness in youth sports across the United States.
  • Boston Red SoxflagshipGTM or Marketing PartnerZOLL is the Official AED provider for Fenway Park and the Boston Red Sox, establishing the venue as a model for cardiac preparedness. This partnership positions ZOLL as the trusted AED brand in high-profile sports settings.
  • National Emergency AED RegistrycoreStrategic or Co-development PartnerZOLL participates in the National Emergency AED Registry (NEAR) managed by PulsePoint Foundation, with approximately 212,000 of estimated 1.1 million AEDs deployed nationwide currently registered in the system.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

ZOLL Medical Corporation competitors and assessment

Company assessment

Direct peers

  • Stryker: Owns Physio-Control/LifePak and HeartSine — the most direct global competitor to ZOLL's monitor/defibrillators and AED lines. Competes head-to-head in EMS, hospital, and public-access defibrillation.
  • Medtronic: Major cardiac rhythm management incumbent (ICDs, CRT, ablation) and one of the three majority-share holders in sleep apnea implants alongside ZOLL. Direct competitor across implantable and adjacent cardiac device categories.
  • Boston Scientific: Cardiac rhythm management and electrophysiology competitor. Competes in hospital cardiology where ZOLL's LifeVest, X Series, and RescueNet are deployed, and has growing sleep apnea/surgical franchises.
  • Inspire Medical Systems: Direct competitor in the implantable sleep apnea market — Inspire's hypoglossal nerve stimulation competes head-to-head with ZOLL's remedē System for central sleep apnea treatment.
  • Abbott: Cardiovascular and cardiac rhythm management (ICDs, CRT-D) competitor; also competes in hospital diagnostics and remote monitoring relevant to ZOLL's TRENDS and RescueNet ecosystem.
  • ResMed: Global leader in sleep apnea (PAP therapy, masks, diagnostics). Competes with ZOLL Itamar (WatchPAT, remedē) in the sleep apnea diagnosis and treatment continuum.
  • Nihon Kohden: Japanese patient monitoring and defibrillator manufacturer with overlapping product categories — particularly relevant as a regional competitor in APAC and EMS/hospital monitoring.

Broad incumbents

  • Koninklijke Philips N.V. Historically competed with HeartStart AEDs and has overlapping patient-monitoring/hospital informatics offerings. Broader portfolio but meaningful overlap in hospital resuscitation and connected care.
  • GE HealthCare: Hospital-wide patient monitoring and anesthesia/critical care portfolio overlaps ZOLL's hospital, critical care, and connected-care offerings; broad incumbent rather than cardiac specialist.

Emerging players

  • Mindray: Chinese medical device maker with growing global share in patient monitoring, AEDs, and defibrillators. Increasingly competitive on price-performance in EMS and emerging markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

ZOLL Medical Corporation social profiles

Digital presence

ZOLL Medical Corporation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ZOLL Medical Corporation leadership team

Management profile

Number of profiles

Profiles5 records

ZOLL Medical Corporation subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

ZOLL Medical Corporation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ZOLL Medical Corporation M&A and investment

M&A and investment

M&A15 records

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZOLL Medical Corporation

What does ZOLL Medical Corporation do?

ZOLL Medical Corporation develops, manufactures, and markets professional medical devices and software for cardiopulmonary resuscitation, cardiac monitoring and defibrillation, temperature management, automated CPR, sleep apnea diagnosis and treatment, and EMS/hospital data management. Its portfolio spans automated external defibrillators (AEDs), professional monitor/defibrillators, the LifeVest wearable cardioverter-defibrillator, WatchPAT home sleep apnea tests, the remedē System implantable central sleep apnea device, TherOx SuperSaturated Oxygen Therapy, Thermogard temperature management systems, the AutoPulse automated CPR platform, and the RescueNet software suite (CaseReview, CodeWriter, CodeNet, Live, 12-Lead, EventSummary, DeviceDashboard, PlusTrac, emsCharts, Dispatch, Billing, AR Boost, Care Exchange). Customers include EMS agencies, hospitals, government/military buyers, public access venues, and cardiac patients across more than 30 countries.

Is ZOLL Medical Corporation a public or private company?

ZOLL Medical Corporation is a private company. It is classified as corporate owned and is currently operating.

When was ZOLL Medical Corporation founded?

ZOLL Medical Corporation was founded in 1980. It employs 1,001 to 5,000 people.

Where is ZOLL Medical Corporation based?

ZOLL Medical Corporation is headquartered in Chelmsford, United States, in the North America region.

How does ZOLL Medical Corporation make money?

Five revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are software Subscriptions and Licensing, accessories and Consumables, therapy Devices and service and Support.

Who are ZOLL Medical Corporation's main competitors?

Direct peers on record are Stryker, Medtronic, Boston Scientific, Inspire Medical Systems, Abbott, ResMed and Nihon Kohden. Broad incumbents are Koninklijke Philips N.V. and GE HealthCare. Mindray is listed as an emerging player.

Does ZOLL Medical Corporation have an API?

No public API is recorded for ZOLL Medical Corporation.

What industry is ZOLL Medical Corporation in?

ZOLL Medical Corporation's product category is Medical Devices and Software for Cardiopulmonary Resuscitation. Its primary akta.pro industry code is HLAHAFAC, Cardiac Rhythm Management (Pacemakers, ICDs, CRT), with a secondary code of HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation). Its NAICS code is 62 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesAutomated Cardiopulmonary Resuscitation Machine Market to Reach US$ 553.05 Million by 2034 – PR TimesThe automated cardiopulmonary resuscitation machine market is projected to grow from US$ 242.68 million in 2025 to US$ 553.05 million by 2034, driven by the need for consistent CPR quality and rising cardiac arrest cases. Key growth factors include expanding emergency medical infrastructure and technological innovations such as portable, battery-powered, and AI-enabled devices. The report identifies major industry players including ZOLL Medical Corporation, Koninklijke Philips N.V., Abbott, and Stryker.PR NewswireVentilators Market worth $3.10 billion by 2031 - Exclusive Report by MarketsandMarkets™The ventilators market is projected to grow from $2.49 billion in 2026 to $3.10 billion by 2031, a 4.4% CAGR. Portable ventilators are expected to reach $857.1 million by 2031, and Asia Pacific is the fastest-growing region. Intensive care ventilators and adult/pediatric segments hold the largest shares.ClinicaltrialvanguardZoll Medical’s FDA Warning Letter Reveals the QC Failure Sponsors Keep FundingThe FDA issued a warning letter to Zoll Medical Corporation on April 30, 2026, following a two-month inspection of the company's Chelmsford, Massachusetts facility from February to April 2025, during which multiple quality control violations under 21 CFR Part 820 and Medical Device Reporting failures under 21 CFR Part 803 were documented. The fourteen-month gap between inspection close and formal enforcement issuance meant sponsors running clinical trials with Zoll equipment during that window made vendor qualification decisions without visibility into the unresolved FDA observations. The article argues that sponsors bear ultimate accountability under ICH E6(R3) for device vendor quality failures and recommends implementing real-time FDA enforcement database checks as part of trial vendor management processes.Medical BuyerFDA warns Zoll Medical over manufacturing violationsFDA issued a warning letter to Zoll Medical Corporation following an inspection of its Chelmsford, Massachusetts facility from February 27 to April 15, 2025, that uncovered significant Quality System Regulation violations affecting critical medical devices including X Series AEDs, MRI-compatible ventilators, and electrodes. The FDA determined these devices are "adulterated" and "misbranded" under the Federal Food, Drug, and Cosmetic Act, citing failures such as rejecting a CAPA for burnt electrodes that could arc and burn patients, delaying a Class I recall for MRI ventilators by 21 days, and failing to submit required malfunction reports within the 30-calendar day timeframe. The agency warned that failure to adequately address the violations may result in regulatory actions including seizure, injunction, and civil money penalties.FortunebusinessinsightsSleep Apnea Implants Market Size, ShareThe global sleep apnea implants market was valued at USD 640.3 million in 2025 and is projected to grow to USD 1,888.7 million by 2034, representing a compound annual growth rate of 12.7%. North America dominated the market with a 46.68% share in 2025, driven by strong adoption of implant therapies and the presence of major industry participants. Key players including Medtronic, Inspire Medical Systems, and ZOLL Medical Corporation held the majority of market share, while recent regulatory milestones such as FDA approvals for Inspire V and an FDA Approvable Letter for Nyxoah's Genio system signal continued industry momentum.UmlRipple Effect: Readers Establish Mentorship Program at Manning School | NewsDoug and Michelle Reader established the Reader Family Industry Mentorship Program at UMass Lowell's Manning School of Business with a $200,000 gift to connect students with alumni mentors. The pilot program launched in spring, matching 45 students with 50 industry professionals from organizations such as Loomis Sayles, BLU NXT, and ZOLL Medical for career development support.EIN PresswireJoin Carmel Marathon Weekend on May 30-31, 2026Carmel Marathon Weekend on May 30-31, 2026, will become the first marathon to implement Bolt for the Heart's Rescue Ready Race program, powered by ZOLL. The program includes strategic AED placement, trained volunteers, and emergency communication protocols. Indy Auto Man is supporting the initiative in Indiana.Business Wire BlogNew Data: LifeVest® Wearable Defibrillator is Useful Tool for Quicker Beta-Blocker Optimization in WomenZOLL presented data from the OPT-BB Women study at ESC-HF 2026, showing LifeVest wearable defibrillator helped achieve better heart rate control in female heart failure patients. Heart rate control was adequate in 80% of women, up from 57% at diagnosis, indicating quicker beta-blocker optimization. The study highlights the device's role in reducing sudden cardiac death risk during therapy optimization.openPR.comCardiac Arrhythmia Therapeutics Market Size, Share, Growth, Analysis and Forecast 2032Credence Research published a market intelligence report estimating the global Cardiac Arrest Treatment market at USD 5,213 million in 2025, projected to reach USD 6,999.56 million by 2032 with a 4.3% CAGR, driven by rising sudden cardiac arrest incidence and advancements in defibrillators, ECMO systems, and pharmacological interventions. North America holds approximately 38% market share while Asia Pacific is expected to record the fastest growth at around 31%, supported by improving healthcare infrastructure and emergency response systems. The report identifies key market players including Koninklijke Philips N.V., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Novartis AG, ZOLL Medical Corporation, GE HealthCare, and Stryker Corporation, noting they are investing in AI-assisted devices and next-generation defibrillators to maintain competitive positioning.openPR.comGlobal Factors Shaping the Rapid Evolution of the Temperature Management MarketThe temperature management market is projected to grow from its current size to $3.72 billion by 2030, representing a compound annual growth rate of 5.1%, driven by rising surgical volumes, expanded critical care services, and increased demand for patient warming and cooling systems in hospitals and surgical centers. In August 2024, Samsung Medison Co., Ltd. acquired France-based Sonio, a developer of 3D and 5D ultrasound devices, aiming to integrate advanced fetal imaging technology with maternal healthcare solutions. A separate July 2023 partnership granted ZOLL Medical Corporation exclusive distribution rights for BrainCool's temperature management products across the United States and major European markets.